Table 4.
Outcomes | Neostigmine | Odds ratio (95% CI) | Neuromuscular transmission monitoring | Odds ratio (95% CI) | |||
---|---|---|---|---|---|---|---|
Not administered (n=21 117) | Administered (n=16 041) | Not applied (n=24 281) | Applied (n=12 877) | ||||
Desaturation <90% | 810 | 804 | 1.32 (1.20 to 1.46) | 993 | 621 | 1.19 (1.07 to 1.32) | |
Desaturation <80% | 180 | 160 | 1.17 (0.95 to 1.45) | 211 | 129 | 1.15 (0.93 to 1.44) | |
Reintubation | 111 | 148 | 1.76 (1.38 to 2.26) | 145 | 114 | 1.49 (1.16 to 1.90) | |
In-hospital death | 58 | 45 | 1.02 (0.69 to 1.51) | 66 | 37 | 1.06 (0.71 to 1.58) |